Insights
Search Results
News Articles
6.05.26
Wilson Sonsini Attorneys Named to Lawdragon’s 2026 List of Next-Generation Lawyers
Ten Wilson Sonsini attorneys have been recognized in the 2026 edition of Lawdragon 500 X – The Next Generation. Individuals listed in the guide are “the future of the law” and are recognized for their accomplishments in their career thus far.
Client Highlights
6.01.26
Wilson Sonsini Advises Credo on Regulatory Matters Related to Acquisition of DustPhotonics
On May 28, 2026, Credo Technology Group Holding Ltd (Credo), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, announced that it has completed its acquisition of DustPhotonics in a transaction valued up to $1.3 billion. DustPhotonics brings industry-leading silicon photonics photonic integrated circuit (SiPho PIC) technology for optical connectivity, deepening Credo’s optical interconnect portfolio across 800G, 1.6T, and 3.2T near-packaged optics (NPO) and co-packaged optics (CPO). Wilson Sonsini Goodrich & Rosati advised Credo on regulatory matters related to the transaction.
Alerts
5.18.26
The “Friendly Buyer” Fallacy: Why U.S. Ownership Is No Longer a Regulatory Safe Bet
Over the past decade, the number of countries with foreign direct investment (FDI) screening regimes has more than doubled. What was once a niche, rarely-used regulatory tool has become a standard feature of global deal-making and a routine consideration in cross-border M&A, including U.S. to U.S. transactions that involve the indirect acquisition of foreign subsidiaries. As jurisdictions continue to strengthen their FDI screening regimes, parties are seeing more U.S.-led deals encounter longer and more intrusive reviews and increasingly complex conditions as a condition of approval.
Client Highlights
5.05.26
Wilson Sonsini Advises Lattice Semiconductor on $1.65 Billion Acquisition of AMI
On May 4, 2026, Lattice Semiconductor announced it has entered into a definitive agreement with THL Partners to acquire AMI, a leader in platform firmware and infrastructure manageability for cloud and AI. The planned acquisition advances Lattice Semiconductor’s strategy to expand its position in server, AI, and cloud applications spanning hardware, security, manageability, and control. Wilson Sonsini Goodrich & Rosati is advising Lattice Semiconductor on the transaction.
Client Highlights
4.09.26
Firm Advises Marvell Technology on Strategic Partnership and $2 Billion Investment from NVIDIA
On March 31, 2026, NVIDIA announced it has invested $2 billion in Marvell Technology as part of a strategic partnership to connect Marvell to the NVIDIA AI factory and AI-RAN ecosystem through NVIDIA NVLink Fusion™. This partnership offers customers building on NVIDIA architectures greater choice and flexibility in developing next-generation infrastructure. The companies will also collaborate on silicon photonics technology. Wilson Sonsini Goodrich & Rosati advised Marvell on the transaction.
Alerts
4.06.26
FTC Announcement of Healthcare Task Force Coincides with Joint DOJ/FTC Appearance at ONC Annual Meeting
Two recent developments suggest that enforcers are poised to grapple with antitrust concerns in health tech, signaling an escalation of scrutiny into Information Blocking1 tactics that have persisted despite U.S. Department of Health and Human Services (HHS) rules and regulations designed to curtail such practices. Stakeholders and industry participants should be prepared for potential outreach.
Client Highlights
3.03.26
Wilson Sonsini Advises Versori on Acquisition by Avalara
On February 27, 2026, Avalara, the leading provider of cloud-based tax compliance automation software, announced that it acquired Versori Group, an integration platform company specializing in automated connector development powered by agentic AI. Wilson Sonsini Goodrich & Rosati advised Versori on the transaction.
Alerts
2.10.26
“Landmark” Settlement in PBM Case Poised to Broadly Reshape Prescription Drug Market
On February 4, 2026, the Federal Trade Commission (FTC) announced a settlement and consent order in a long-running administrative action against pharmacy benefit managers (PBMs) Express Scripts, OptumRx, and Caremark Rx. The FTC alleged that these three PBMs, which have a collective U.S. market share of approximately 80 percent, deployed anticompetitive and unfair rebating practices that artificially inflated the list price of insulin drugs by systematically preferring higher-priced drugs at the exclusion of lower cost products. The settlement resolves the claims as to Express Scripts and its family of companies.
News Articles
1.16.26
Firm Attorneys Named to 2026 Lawdragon 500 Leading Global Antitrust & Competition Lawyers
On January 16, 2026, 15 Wilson Sonsini attorneys were selected for inclusion in Lawdragon’s “500 Leading Antitrust & Global Competition Lawyers” guide. The lawyers featured are recognized for navigating global antitrust regulatory regimes, representing clients in massive competition contests, and navigating frameworks of countries and markets globally.
Client Highlights
1.06.26
Wilson Sonsini Advises Marvell on $540 Million Acquisition of XConn Technologies
On January 6, 2026, Marvell Technology, a leader in data infrastructure semiconductor solutions, announced it has entered into a definitive agreement to acquire XConn Technologies, a provider of advanced PCIe and CXL switching silicon. Wilson Sonsini Goodrich & Rosati is advising Marvell on the transaction.
Client Highlights
11.04.25
Firm Advises Automation Anywhere on Acquisition of Aisera
On November 4, 2025, Automation Anywhere, the leading provider of Agentic Process Automation (APA) and agentic solutions, announced it has acquired Aisera, the leading provider of agentic solutions for autonomous IT. The acquisition expands Automation Anywhere’s deep AI portfolio and expertise in automating mission-critical enterprise processes with Aisera’s industry-leading self-service agents for IT Service Management (ITSM), HR, and Customer Service—creating the industry’s most comprehensive agentic automation portfolios to deliver autonomous operations across departments and improve employee and customer experience. Wilson Sonsini Goodrich & Rosati advised Automation Anywhere on the transaction.
Client Highlights
10.22.25
Wilson Sonsini Advises Phare Health on Acquisition by R1
Wilson Sonsini’s London-based M&A team advised Phare Health Ltd, a healthcare technology company building AI-native solutions for inpatient coding and clinical documentation improvement, on its sale to R1 (an industry leader in managing and intelligently automating healthcare revenue management).